公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2008 | Association of galactose single-point test levels and phenytoin metabolic polymorphisms with gingival hyperplasia in patients receiving long-term phenytoin therapy | CHUN-JUNG LIN ; Yen M.-F.; Hu O.Y.-P.; Lin M.-S.; Hsiong C.-H.; Hung, Chin-Chuan; HORNG-HUEI LIOU | Pharmacotherapy | 7 | 6 | |
2012 | Association of polymorphisms in EPHX1, UGT2B7, ABCB1, ABCC2, SCN1A and SCN2A genes with carbamazepine therapy optimization | Hung, Chin-Chuan; Chang, Wei-Lun; Ho, Jia-Ling; Tai, John Jen; Hsieh, Tsung-Jen; Huang, Hsiao-Ching; Hsieh, Yow-Wen; Liou, Horng-Huei | Pharmacogenomics | 43 | 58 | |
2007 | ASSOCIATION OF POLYMORPHISMS IN NR1I 2 AND ABCB1 GENES WITH EPILEPSY TREATMENT RESPONSES | Hung, Chin-Chuan; Tai, John Jen; Kao, Pi-Ju; Lin, Min-Shung; Liou, Horng-Huei | PHARMACOGENOMICS | | | |
2006 | A Common Polymorphism in the Scn1a Gene Associates with Phenytoin Serum Levels at Maintenance Dose | HUNG, CHIN-CHUAN; TAI, JOHN JEN; LIOU, HORNG-HUEI | PHARMACOGENETICS AND GENOMICS | | | |
2005 | Complex haplotypic effects of the ABCB1 gene on epilepsy treatment response | Hung, Chin-Chuan; Tai J.J.; CHUN-JUNG LIN ; MING-JEN LEE ; HORNG-HUEI LIOU | Pharmacogenomics | 118 | 102 | |
2004 | Dosage recommendation of phenytoin for patients with epilepsy with different CYP2C9/CYP2C19 polymorphisms | Hung, Chin-Chuan; CHUN-JUNG LIN ; Chen, Chih-Chuan; Chang C.-J.; HORNG-HUEI LIOU | Therapeutic Drug Monitoring | 115 | 93 | |
2008 | Functional evaluation of polymorphisms in the human ABCB1 gene and the impact on clinical responses of antiepileptic drugs | Hung, Chin-Chuan; Chen, Chih-Chuan; CHUN-JUNG LIN ; HORNG-HUEI LIOU | Pharmacogenetics and Genomics | 54 | 49 | |
2005 | IMPACT OF COMPLEX POLYMORPHIC SYSTEM OF ABCB1 GENE ON THE EPILEPSY TREATMENT OUTCOME. | HUNG, CHIN-CHUAN; TAI, JOHN, JEN; LIN, CHUN-JUNG | PHARMACOGENOMICS | | | |